The number of clinical trials in which AI designed or repurposed molecules, or targeted diseases, has more than doubled since ...

Algernon Pharmaceuticals Inc., a Canadian clinical stage pharmaceutical development company, announced that its wholly owned subsidiary, Algernon NeuroScience (AGN Neuro), has appointed Validcare as ...

Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...

Scientists and organizations are attempting to preserve data by saving it to Substack accounts and personal websites. They're also trying to figure out a new system to share health data, The Hill said ...

Pliant Therapeutics halted new enrollment in its BEACON-IPF trial after a safety board review. A separate study showed ...

Rhapsody’s Chief Product Officer Jitin Asnaani discusses how to connect the dots between disparate patient records from multiple specialist departments to create a clear picture of patient needs.

Pliant Therapeutics, a Californian biopharma focused on discovering and developing fibrosis drugs, saw its shares close down ...

The FDA announced the approval of a new treatment for pneumonia caused by certain difficult-to-treat bacteria, offering hope ...

Antares Vision Group, an Italian multinational leading provider in Track & Trace systems and quality control, which ...

Amid a shakeup in U.S. science, researchers are expressing alarm over the integrity of key genetic databases overseen by the ...